Very quite in here, in regards to the ABC report no doubt it's to clean up "backyard stem sellers " we don't need them tainting the companies going thru costly trials etc etc ...Below is a takeaway conclusion of the latest Lodge partners report out earlier this week ......The data coming out with research to Repentance do apgvhd indicates that the major risk that Mesoblast faces is the execution risk with regulatory matters .Mesoblast has never had a problem with execution and even thou the preparation of a BLA is a magnitude of the order greater than any other single regulatory hurdle Mesoblast has faced ,the quality of staff within the company leaves us very comfortable ,the execution risk is negitable as a consequence we rate MSB as a strong buy ... V
Cell Therapy News/Articles, page-174
-
- There are more pages in this discussion • 17,599 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.09 |
Change
-0.050(4.39%) |
Mkt cap ! $1.244B | |||
| Open | High | Low | Value | Volume |
| $1.14 | $1.17 | $1.07 | $8.385M | 7.489M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 8500 | $1.08 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.09 | 26954 | 3 |
View Market Depth
| Last trade - 16.10pm 19/06/2024 (20 minute delay) ? |
| MSB (ASX) Chart |